Hydroxyurea 500 mg as Supportive Therapy in Resistant CML

Hydroxyurea 500 mg as Supportive Therapy in Resistant CML

Managing resistant cases of Chronic Myeloid Leukemia (CML) can be complex and requires a carefully structured treatment strategy. While targeted therapies are the primary approach in CML management, supportive medications may play an important role in controlling...

nagatop

nagatop

slot online

slot gacor

mahjong88

mahjong88